Toward development and production of human t cells in swine for potential use in adoptive T cell immunotherapy

Tissue Engineering - Part A

Volumn 15, Issue 5, 2009, Pages 1031-1040

  Ogle, Brenda M ^a   Knudsen, Bruce E ^a   Nishitai, Ryuta ^b   Ogata, Kiyoshi ^c   Platt, Jeffrey L ^a,d  

^a MAYO CLINIC   (United States)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; BONE; CELL MEMBRANES;

ANTIGEN PRESENTING CELLS; BONE MARROW; HEMATOPOIETIC STEM CELLS; HUMAN BONE MARROW CELLS; HUMAN T CELLS; SURROGATE HOST; T CELLS;

CYTOLOGY;

T LYMPHOCYTE RECEPTOR;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW CELL; CELL MATURATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENGRAFTMENT; EXPERIMENTAL PIG; FETUS; HEMATOPOIETIC STEM CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T CELL DEPLETION; T LYMPHOCYTE; THYMUS;

SUIDAE;

EID: 66249114984     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2008.0117     Document Type: Article

References (55)

1. Gilboa, E. The promise of cancer vaccines. Nat Rev Cancer 4, 401, 2004.
2. Mocellin, S., Mandruzzato, S., Bronte, V., Lise, M., and Nitti, D. Part I: vaccines for solid tumours. Lancet Oncol 5, 681, 2004.
3. Letvin, N.L., and Walker, B.D. Immunopathogenesis and immunotherapy in AIDS virus infections. Nat Med 9, 861, 2003.
4. Tramont, E.C., and Johnston, M.I. Progress in the development of an HIV vaccine. Expert Opin Emerg Drugs 8, 37, 2003.
5. Rosenberg, S.A., Yang, J.C., Schwartzentruber, D.J., Hwu, P., Marincola, F.M., Topalian, S.L., Restifo, N.P., Dudley, M.E., Schwarz, S.L., Spiess, P.J., Wunderlich, J.R., Parkhurst, M.R., Kawakami, Y., Seipp, C.A., Einhorn, J.H., and White, D.E. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med 4, 321, 1998.
6. Salgia, R., Lynch, T., Skarin, A., Lucca, J., Lynch, C., Jung, K., Hodi, F.S., Jaklitsch, M., Mentzer, S., Swanson, S., Lukanich, J., Bueno, R., Wain, J., Mathisen, D., Wright, C., Fidias, P., Donahue, D., Clift, S., Hardy, S., Neuberg, D., Mulligan, R., Webb, I., Sugarbaker, D., Mihm, M., and Dranoff, G. Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma. J Clin Oncol 21, 624, 2003.
7. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., and Steinman, R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176, 1693, 1992.
8. Caux, C., Dezutter-Dambuyant, C., Schmitt, D., and Banchereau, J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360, 258, 1992.
9. Slingluff, C.L., Jr., Petroni, G.R., Yamshchikov, G.V., Barnd, D.L., Eastham, S., Galavotti, H., Patterson, J.W., Deacon, D.H., Hibbitts, S., Teates, D., Neese, P.Y., Grosh, W.W., Chianese-Bullock, K.A., Woodson, E.M., Wiernasz, C.J., Merrill, P., Gibson, J., Ross, M., and Engelhard, V.H. Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells. J Clin Oncol 21, 4016, 2003.
10. Zhou, G., Lu, Z., McCadden, J.D., Levitsky, H.I., and Marson, A.L. Reciprocal changes in tumor antigenicity and antigen-specific T cell function during tumor progression. J Exp Med 200, 1581, 2004.
11. Killian, M.S., Monteiro, J., Matud, J., Hultin, L.E., Hausner, M.A., Yang, O.O., Gregersen, P.K., Detels, R., Giorgi, J.V., and Jamieson, B.D. Persistent alterations in the T-cell repertoires of HIV-1-infected and at-risk uninfected men. AIDS 18, 161, 2004.
12. Staveley-O'Carroll, K., Sotomayor, E., Montgomery, J., Borrello, I., Hwang, L., Fein, S., Pardoll, D., and Levitsky, H. Induction of antigen-specific T cell anergy: an early event in the course of tumor progression. Proc Natl Acad Sci USA 95, 1178, 1998.
13. Casella, C.R., and Finkel, T.H. Mechanisms of lymphocyte killing by HIV. Curr Opin Hematol 4, 24, 1997.
14. McMichael, A.J., and Rowland-Jones, S.L. Cellular immune responses to HIV. Nature 410, 980, 2001.
15. Kostense, S., Raaphorst, F.M., Joling, J., Notermans, D.W., Prins, J.M., Danner, S.A., Reiss, P., Lange, J.M., Teale, J.M., and Miedema, F. T cell expansions in lymph nodes and peripheral blood in HIV-1-infected individuals: effect of antiretroviral therapy. AIDS 15, 1097, 2001.
16. Markert, M.L., Sarzotti, M., Ozaki, D.A., Sempowski, G.D., Rhein, M.E., Hale, L.P., Le Deist, F., Alexieff, M.J., Li, J., Hauser, E.R., Haynes, B.F., Rice, H.E., Skinner, M.A., Mahaffey, S.M., Jaggers, J., Stein, L.D., and Mill, M.R. Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients. Blood 102, 1121, 2003.
17. Markert, M.L., Alexieff, M.J., Li, J., Sarzotti, M., Ozaki, D.A., Devlin, B.H., Sedlak, D.A., Sempowski, G.D., Hale, L.P., Rice, H.E., Mahaffey, S.M., and Skinner, M.A. Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome. Blood 104, 2574, 2004.
18. Freedman, A.R., Zhu, H., Levine, J.D., Kalams, S., and Scadden, D.T. Generation of human T lymphocytes from bone marrow CD34+ cells in vitro. Nat Med 2, 46, 1996.
19. Pawelec, G., Muller, R., Rehbein, A., Hahnel, K., and Ziegler, B.L. Extrathymic T cell differentiation in vitro from human CD34+ stem cells. J Leukoc Biol 64, 733, 1998.
20. Fisher, A.G., Larsson, L., Goff, L.K., Restall, D.E., Happerfield, L., and Merkenschlager, M. Human thymocyte development in mouse organ cultures. Int Immunol 2, 571, 1990.
21. Plum, J., De Smedt, M., Defresne, M.P., Leclercq, G., and Vandekerckhove, B. Human CD34+ fetal liver stem cells differentiate to T cells in a mouse thymic microenvironment. Blood 84, 1587, 1994.
22. Poznansky, M.C., Evans, R.H., Foxall, R.B., Olszak, I.T., Piascik, A.H., Hartman, K.E., Brander, C., Meyer, T.H., Pykett, M.J., Chabner, K.T., Kalams, S.A., Rosenzweig, M., and Scadden, D.T. Efficient generation of human T cells from a tissue-engineered thymic organoid. Nat Biotechnol 18, 729, 2000.
23. Rothkotter, H.J., Sowa, E., and Pabst, R. The pig as a model of developmental immunology. Hum Exp Toxicol 21, 533, 2002.
24. Tran, N.D., Porada, C.D., Almeida-Porada, G., Glimp, H.A., Anderson, W.F., and Zanjani, E.D. Induction of stable prenatal tolerance to beta-galactosidase by in utero gene transfer into preimmune sheep fetuses. Blood 97, 3417, 2001.
25. Zanjani, E.D., Pallavicini, M.G., Ascensao, J.L., Flake, A.W., Langlois, R.G., Reitsma, M., MacKintosh, F.R., Stutes, D., Harrison, M.R., and Tavassoli, M. Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero. J Clin Invest 89, 1178, 1992.
26. Nikolic, B., Gardner, J.P., Scadden, D.T., Arn, J.S., Sachs, D.H., and Sykes, M. Normal development in porcine thymus grafts and specific tolerance of human T cells to porcine donor MHC. J Immunol 162, 3402, 1999.
27. Ogle, B.M., Butters, K.B., Plummer, T.B., Ring, K.R., Knudsen, B., Litzow, M.R., Cascalho, M., and Platt, J.L. Spontaneous fusion of cells between species yields trans-differentiation and retroviral in vivo. FASEB J 18, 548, 2004.
28. Hazenberg, M.D., Verschuren, M.C., Hamann, D., Miedema, F., and van Dongen, J.J. T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. J Mol Med 79, 631, 2001.
29. Steffens, C.M., Al-Harthi, L., Shott, S., Yogev, R., and Landay, A. Evaluation of thymopoiesis using T cell receptor excision circles (TRECs): differential correlation between adult and pediatric TRECs and naive phenotypes. Clin Immunol 97, 95, 2000.
30. Douek, D.C., Vescio, R.A., Betts, M.R., Brenchley, J.M., Hill, B.J., Zhang, L., Berenson, J.R., Collins, R.H., and Koup, R.A. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 355, 1875, 2000.
31. Douek, D.C., and Koup, R.A. Evidence for thymic function in the elderly. Vaccine 18, 1638, 2000.
32. Ogle, B.M., Cascalho, M., Joao, C.M., Taylor, W.R., West, L.J., and Platt, J.L. Direct measurement of lymphocyte receptor diversity. Nucleic Acids Res 31, e139, 2003.
33. Ogle, B.M., West, L.J., Driscoll, D.J., Strome, S.E., Razonable, R.R., Paya, C.V., Cascalho, M., and Platt, J.L. Effacing of the T cell compartment by cardiac transplantation in infancy. J Immunol 176, 1962, 2006.
34. AbuAttieh, M., Rebrovich, M., Wettstein, P.J., Vuk-Pavlovic, Z., Limper, A.H., Platt, J.L., and Cascalho, M. Fitness of cell-mediated immunity independent of repertoire diversity. J Immunol 178, 2950, 2007.
35. Cascalho, M., and Platt, J.L. The immunological barrier to xenotransplantation. Immunity 14, 437, 2001.
36. Jantscheff, P., Herrmann, R., Spagnoli, G., Reuter, J., Mehtali, M., Courtney, M., and Rochlitz, C. Gene therapy with cytokine-transfected xenogenic cells (Vero-IL-2) in patients with metastatic solid tumors: mechanism(s) of elimination of the transgene-carrying cells. Cancer Immunol Immunother 48, 321, 1999.
37. Beschorner, W.E., Qian, Z., Mattei, P., Hess, A.D., Colombani, P.M., Sciscione, A.C., Khouzami, A., Blakemore, K.J., and Burdick, J.F. Induction of human chimerism and functional suppressor cells in fetal pigs: feasibility of surrogate tolerogenesis for xenotransplantation. Transplant Proc 28, 648, 1996.
38. Beschorner, W., Sudan, D., Yang, T., Radio, S., Stammers, A., Johnson, N., Shearon, C., Kuszynski, C., Dixon, R.S., Matamoros, A., and Langnas, A. Surrogate tolerogenesis: possible pretransplant induction of accommodation of pig xenografts. Transplant Proc 32, 994, 2000.
39. Fujiki, Y., Fukawa, K., Kameyama, K., Kudo, O., Onodera, M., Nakamura, Y., Yagami, K., Shiina, Y., Hamada, H., Shibuya, A., and Nakauchi, H. Successful multilineage engraftment of human cord blood cells in pigs after in utero transplantation. Transplantation 75, 916, 2003.
40. Zanjani, E.D., Flake, A.W., Rice, H., Hedrick, M., and Tavassoli, M. Long-term repopulating ability of xenogeneic transplanted human fetal liver hematopoietic stem cells in sheep. J Clin Invest 93, 1051, 1994.
41. Srour, E.F., Zanjani, E.D., Brandt, J.E., Leemhuis, T., Briddell, R.A., Heerema, N.A., and Hoffman, R. Sustained human hematopoiesis in sheep transplanted in utero during early gestation with fractionated adult human bone marrow cells. Blood 79, 1404, 1992.
42. Srour, E.F., Zanjani, E.D., Cornetta, K., Traycoff, C.M., Flake, A.W., Hedrick, M., Brandt, J.E., Leemhuis, T., and Hoffman, R. Persistence of human multilineage, self-renewing lymphohematopoietic stem cells in chimeric sheep. Blood 82, 3333, 1993.
43. Turner, C.W., Archer, D.R., Wong, J., Yeager, A.M., and Fleming, W.H. In utero transplantation of human fetal haemopoietic cells in NOD/SCID mice. Br J Haematol 103, 326, 1998.
44. Ohishi, K., Varnum-Finney, B., and Bernstein, I.D. Delta-1 enhances marrow and thymus repopulating ability of human CD34(+)CD38(-) cord blood cells. J Clin Invest 110, 1165, 2002.
45. Shultz, L.D., Lyons, B.L., Burzenski, L.M., Gott, B., Chen, X., Chaleff, S., Kotb, M., Gillies, S.D., King, M., Mangada, J., Greiner, D.L., and Handgretinger, R. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174, 6477, 2005.
46. Ishikawa, F., Yasukawa, M., Lyons, B., Yoshida, S., Miyamoto, T., Yoshimoto, G., Watanabe, T., Akashi, K., Shultz, L.D., and Harada, M. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood 106, 1565, 2005.
47. Zhang, B., Ge, B., Xia, X., Liu, J., Sun, L., Rao, E., and Zhao, Y. Compatibility of porcine and human interleukin 2: implications for xenotransplantation. Xenotransplantation 13, 423, 2006.
48. Arstila, T.P., Casrouge, A., Baron, V., Even, J., Kanellopoulos, J., and Kourilsky, P. A direct estimate of the human alphabeta T cell receptor diversity. Science 286, 958, 1999.
49. Martin, W.D., Hicks, G.G., Mendiratta, S.K., Leva, H.I., Ruley, H.E., and van Kaer, L. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell 84, 543, 1996.
50. Zhao, Y., Rodriguez-Barbosa, J.I., Shimizu, A., Sachs, D.H., and Sykes, M. Despite efficient intrathymic negative selection of host-reactive T cells, autoimmune disease may develop in porcine thymus-grafted athymic mice: evidence for failure of regulatory mechanisms suppressing autoimmunity. Transplantation 75, 1832, 2003.
51. Heneine, W., Tibell, A., Switzer, W.M., Sandstrom, P., Rosales, G.V., Mathews, A., Korsgren, O., Chapman, L.E., Folks, T.M., and Groth, C.G. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet 352, 695, 1998.
52. Paradis, K., Langford, G., Long, Z., Heneine, W., Sandstrom, P., Switzer, W.M., Chapman, L.E., Lockey, C., and Onions, D. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science 285, 1236, 1999.
53. Elliott, R.B., Escobar, L., Garkavenko, O., Croxson, M.C., Schroeder, B.A., McGregor, M., Ferguson, G., Beckman, N., and Ferguson, S. No evidence of infection with porcine endogenous retrovirus in recipients of encapsulated porcine islet xenografts. Cell Transplant 9, 895, 2000.
54. Dinsmore, J.H., Manhart, C., Raineri, R., Jacoby, D.B., and Moore, A. No evidence for infection of human cells with porcine endogenous retrovirus (PERV) after exposure to porcine fetal neuronal cells. Transplantation 70, 1382, 2000.
55. Ogle, B.M., Cascalho, M., and Platt, J.L. Biological implications of cell fusion. Nat Rev Mol Cell Biol 6, 567, 2005.